SCHEMBL4605320

SCHEMBL4605320

CC(C)S(=O)(=O)N[C@H]1CCC[C@H]1c1ccc(NC(=O)c2cccc([N+](=O)[O-])c2)cc1

nearest known ligand 0.65

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GRIA4 P48058 12/20 0.65
KMT2A Q03164 4/20 0.55
MEN1 O00255 3/20 0.55
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
CASP3 P42574 1/20 0.53
SENP8 Q96LD8 1/20 0.53
SENP7 Q9BQF6 1/20 0.53
SENP6 Q9GZR1 1/20 0.53
THRA P10827 1/20 0.52
ALDH1A1 P00352 2/20 0.50
MAPT P10636 1/20 0.50
GRIA2 P42262 1/20 0.50
GAA P10253 1/20 0.49
HPGD P15428 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4605315 1.00 GRIA4 (0.65) GRIA4KMT2AMEN1NPC1RAB9A
SCHEMBL4606167 0.89 GRIA4 (0.77) GRIA4KMT2AMEN1NPC1RAB9A
SCHEMBL4606169 0.89 GRIA4 (0.77) GRIA4KMT2AMEN1NPC1RAB9A
SCHEMBL4607636 0.86 GRIA4 (0.57) GRIA4GRIA2
SCHEMBL4607477 0.86 GRIA4 (0.57) GRIA4GRIA2
SCHEMBL4607371 0.85 GRIA4 (0.56) GRIA4GRIA2
SCHEMBL4605829 0.85 GRIA4 (0.56) GRIA4GRIA2
SCHEMBL4607600 0.84 GRIA4 (0.70) GRIA4GRIA2
SCHEMBL4607075 0.84 GRIA4 (0.70) GRIA4GRIA2
SCHEMBL4605831 0.84 GRIA4 (0.55) GRIA4GRIA2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1246797-B1 CYCLOPENTYL SULFONAMIDE DERIVATIVES LILLY CO ELI (US) 2008-07-23 EP claimed
US-6639107-B1 Potentiating glutamate receptor function ELI LILLY AND COMPANY 2003-10-28 US claimed
EP-1246797-A1 CYCLOPENTYL SULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2002-10-09 EP claimed
WO-2001042203-A1 CYCLOPENTYL SULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2001-06-14 WO claimed
EP-1246797-B1 CYCLOPENTYL SULFONAMIDE DERIVATIVES LILLY CO ELI (US) 2008-07-23 EP disclosed
US-6639107-B1 Potentiating glutamate receptor function ELI LILLY AND COMPANY 2003-10-28 US disclosed
EP-1246797-A1 CYCLOPENTYL SULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2002-10-09 EP disclosed
WO-2001042203-A1 CYCLOPENTYL SULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2001-06-14 WO disclosed